Polymeric retinoid prodrug PG-4HPR enhances the radiation response of lung cancer

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 645-651

  Zhu, Guangying ^a,b   Cao, Xianyi ^a   Chang, Joe Y ^a   Milas, Luka ^a   Wallace, Sidney ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

4 HPR; Drug delivery; Poly(L glutamic acid); Radiosensitization

Indexed keywords

ANTINEOPLASTIC AGENT; FENRETINIDE; POLYGLUTAMIC ACID; PRODRUG;

APOPTOSIS; ARTICLE; HUMAN; LUNG TUMOR; NICK END LABELING; PATHOLOGY; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FENRETINIDE; HUMANS; IN SITU NICK-END LABELING; LUNG NEOPLASMS; POLYGLUTAMIC ACID; PRODRUGS;

EID: 38449100847     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.645     Document Type: Article

References (26)

1. Bernier J and Schneider D: Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 43: 35-45, 2006.
2. Eifel PJ: Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 16: 177-185, 2006.
3. Lee JS, Komaki R, Fossella FV, Glisson BS, Hong WK and Cox JD: A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small cell lung cancer: A 5-year follow-up report. Int J Radiat Oncol Biol Phys 42: 479-486, 1998. (Pubitemid 28501094)
4. Liao Z, Komaki R, Stevens C, Kelly J, Fossella F, Lee JS, Allen P and Cox JD: Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIb non-small cell lung cancer. Int J Radiat Oncol Biol Phys 53: 558-565, 2002. (Pubitemid 34626493)
5. Riesterer O, Tenzer A, Zingg D, Hofstetter B, Vuong V, Pruschy M and Bodis S: Novel radiosensitizers for locally advanced epithelial tumors: Inhibition of the pi3k/akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy? Int J Radiat Oncol Biol Phys 58: 361-368, 2004. (Pubitemid 38142460)
6. Maeda H, Wu J, Sawa T, Matsumura Y and Hori K: Tumor vascular permeability and the epr effect in macromolecular therapeutics: A review. J Control Release 65: 271-284, 2000. (Pubitemid 30122932)
7. Ke S, Milas L, Charnsangavej C, Wallace S and Li C: Potentiation of radioresponse by polymer-drug conjugates. J Control Release 74: 237-242, 2001. (Pubitemid 32727626)
8. Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C and Wallace S: Potentiation of ovarian oca-1 tumor radioresponse by poly (l-glutamic acid)-paclitaxel conjugate. Int J Radiat Oncol Biol Phys 48: 1119-1126, 2000.
9. Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C and Wallace S: Tumor irradiation enhances the tumor-specific distribution of poly(l-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res 6: 2829-2834, 2000. (Pubitemid 30482124)
10. Milas L, Mason KA, Hunter N, Li C and Wallace S: Poly(lglutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. Int J Radiat Oncol Biol Phys 55: 707-712, 2003. (Pubitemid 36170011)
11. De Luca LM: Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5: 2924-2933, 1991.
12. Niles RM: Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 555: 81-96, 2004.
13. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795-801, 1990. (Pubitemid 20303877)
14. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S and Mabry M: Growth inhibition and induction of apoptosis by fenretinide in small cell lung cancer cell lines. J Natl Cancer Inst 87: 1674-1680, 1995.
15. Ulukaya E and Wood EJ: Fenretinide and its relation to cancer. Cancer Treat Rev 25: 229-235, 1999. (Pubitemid 29417680)
16. Zou CP, Kurie JM, Lotan D, Zou CC, Hong WK and Lotan R: Higher potency of n-(4-hydroxyphenyl)retinamide than all-trans- retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Clin Cancer Res 4: 1345-1355, 1998. (Pubitemid 28213349)
17. Benbrook D, Shen-Gunther J, Nunez E and Dynlacht J: Differential retinoic acid radiosensitization of cervical carcinoma cell lines. Clin Cancer Res 3: 939-945, 1997. (Pubitemid 27252942)
18. Scribner J, Dennis R and Benbrook DM: Retinoids enhance cisplatin-based chemoradiation in cervical cancer cells in vitro. Gynecol Oncol 85: 223-225, 2002. (Pubitemid 34304041)
19. Zou C, Wang L, Liebert M, Grossman HB, Lotan R and Wei Q: Combined effect of chemopreventive agent n-(4-hydroxyphenyl) retinamide (4-hpr) and gamma-radiation on bladder cancer cell lines. Int J Oncol 13: 1037-1041, 1998. (Pubitemid 28506075)
20. Whitehead CM, Earle KA, Fetter J, Xu S, Hartman T, Chan DC, Zhao TL, Piazza G, Klein-Szanto AJ, Pamukcu R, Alila H, Bunn PA Jr and Thompson WJ: Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Mol Cancer Ther 2: 479-488, 2003.
21. Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG and Li C: Synthesis and characterization of poly(l-glutamic acid) gadolinium chelate: A new biodegradable mri contrast agent. Bioconjug Chem 15: 1408-1415, 2004. (Pubitemid 39552032)
22. Oridate N, Suzuki S, Higuchi M, Mitchell M, Hong W and Lotan R: Involvement of reactive oxygen species in n-(4- hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 89: 1191-1198, 1997. (Pubitemid 27350028)
23. Sun SY, Li W, Yue P, Lippman SM, Hong WK and Lotan R: Mediation of n-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 59: 2493-2498, 1999. (Pubitemid 29242302)
24. Li C: Poly(l-glutamic acid)-anticancer drug conjugates. Adv Drug Deliv Rev 54: 695-713, 2002.
25. Singer JW, Shaffer S, Baker B, Bernareggi A, Stromatt S, Nienstedt D and Besman M: Paclitaxel poliglumex (xyotax; ct-2103): An intracellularly targeted taxane. Anticancer Drugs 16: 243-254, 2005. (Pubitemid 40283939)
26. Renkin EM, Watson PD, Sloop CH, Joyner WM and Curry FE: Transport pathways for fluid and large molecules in microvascular endothelium of the dog's paw. Microvasc Res 14: 205-214, 1977. (Pubitemid 8184247) Human Services